DIVISLAB's weekly performance was disappointing, with a return of -1.99% and a Sharpe Ratio of -0.32, indicating poor risk-adjusted returns. The stock's volatility was high at 24.2%, and it experienced a max drawdown of -2.56%. Compared to its peers, DIVISLAB underperformed DRREDDY and SUNPHARMA, but was in line with CIPLA's performance. Overall, the stock was relatively risky this week.

[Volatility: 24.2%]